483
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Prevalence of asymptomatic Bordetella pertussis and Bordetella parapertussis infections among school children in China as determined by pooled real-time PCR: A cross-sectional study

, , , , , , , , , , , , , & show all
Pages 280-287 | Received 23 Oct 2013, Accepted 15 Dec 2013, Published online: 13 Feb 2014

References

  • Heininger U, Stehr K, Schmitt-Grohe S, Lorenz C, Rost R, Christenson PD, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306–9.
  • Cherry JD, Grimprel E, Guiso N, Heininger U, Mertsola J. Defining pertussis epidemiology: clinical, microbiologic and serologic perspectives. Pediatr Infect Dis J 2005;24:S25–34.
  • Forsyth K, Tan T, von Konig CH, Caro JJ, Plotkin S. Potential strategies to reduce the burden of pertussis. Pediatr Infect Dis J 2005;24:S69–74.
  • Greenberg DP. Pertussis in adolescents: increasing incidence brings attention to the need for booster immunization of adolescents. Pediatr Infect Dis J 2005;24:721–8.
  • Edwards K, Freeman DM. Adolescent and adult pertussis: disease burden and prevention. Curr Opin Pediatr 2006; 18:77–80.
  • Forsyth KD, Wirsing von Konig CH, Tan T, Caro J, Plotkin S. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007;25:2634–42.
  • Palmer CM, McCall B, Jarvinen K, Nissen MD. Bordetella pertussis PCR positivity, following onset of illness in children under 5 years of age. Commun Dis Intell Q Rep 2007; 31:202–5.
  • Long SS, Welkon CJ, Clark JL. Widespread silent transmission of pertussis in families: antibody correlates of infection and symptomatology. J Infect Dis 1990;161:480–6.
  • He Q, Viljanen MK, Nikkari S, Lyytikainen R, Mertsola J. Outcomes of Bordetella pertussis infection in different age groups of an immunized population. J Infect Dis 1994; 170:873–7.
  • Muller FM, Hoppe JE, Wirsing von Konig CH. Laboratory diagnosis of pertussis: state of the art in 1997. J Clin Microbiol 1997;35:2435–43.
  • Emmanuel JC, Bassett MT, Smith HJ, Jacobs JA. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries. J Clin Pathol 1988;41:582–5.
  • Mine H, Emura H, Miyamoto M, Tomono T, Minegishi K, Murokawa H, et al. High throughput screening of 16 million serologically negative blood donors for hepatitis B virus, hepatitis C virus and human immunodeficiency virus type- 1 by nucleic acid amplification testing with specific and sensitive multiplex reagent in Japan. J Virol Methods 2003; 112:145–51.
  • World Health Organization. Laboratory manual for the diagnosis of whooping cough caused by Bordetella pertussis/Bordetella parapertussis. Geneva: WHO; 2004.
  • Zhang Q, Zheng H, Liu M, Han K, Shu J, Wu C, et al. The seroepidemiology of immunoglobulin G antibodies against pertussis toxin in China: a cross-sectional study. BMC Infect Dis 2012;12:138.
  • Kösters K, Reischl U, Schmetz J, Riffelmann M, Wirsing von König CH. Real-Time LightCycler PCR for detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 2002;40:1719–22.
  • Bidet P, Liguori S, De Lauzanne A, Caro V, Lorrot M, Carol A, et al. Real-time PCR measurement of persistence of Bordetella pertussis DNA in nasopharyngeal secretions during antibiotic treatment of young children with pertussis. J Clin Microbiol 2008;46:3636–8.
  • Gordon M, Davies HD, Gold R. Clinical and microbiologic features of children presenting with pertussis to a Canadian pediatric hospital during an eleven-year period. Pediatr Infect Dis J 1994;13:617–22.
  • China Information System for Diseases Control and Prevention. China CDC; 2012. Available at: http://10.249.1.170 (accessed).
  • World Health Organization. WHO vaccine-preventable diseases: monitoring system, 2010 global summary 2010. Available at: http://whqlibdoc.who.int/hq/2010/WHO_IVB_2010_eng.pdf (accessed).
  • Riffelmann M, Littmann M, Hulsse C, von Konig CH. Antibody decay after immunisation of health-care workers with an acellular pertussis vaccine. Eur J Clin Microbiol Infect Dis 2009;28:275–9.
  • McIntyre PB, Turnbull FM, Egan AM, Burgess MA, Wolter JM, Schuerman LM. High levels of antibody in adults three years after vaccination with a reduced antigen content diphtheria–tetanus–acellular pertussis vaccine. Vaccine 2004;23:380–5.
  • Witt MA, Katz PH, Witt DJ. Unexpectedly limited durability of immunity following acellular pertussis vaccination in preadolescents in a North American outbreak. Clin Infect Dis 2012;54:1730–5.
  • Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013;131:e1047–52.
  • Dalby T, Petersen JW, Harboe ZB, Krogfelt KA. Antibody responses to pertussis toxin display different kinetics after clinical Bordetella pertussis infection than after vaccination with an acellular pertussis vaccine. J Med Microbiol 2010;59:1029–36.
  • Hallander HO, Nilsson L, Gustafsson L. Is adolescent pertussis vaccination preferable to natural booster infections?Expert Rev of Clin Pharmacol 2011;7:705–11.
  • Cherry JD. The epidemiology of pertussis: a comparison of the epidemiology of the disease pertussis with the epidemiology of Bordetella pertussis infection. Pediatrics 2005;115:1422–7.
  • de Greeff SC, de Melker HE, van Gageldonk PG, Schellekens JF, van der Klis FR, Mollema L, et al. Seroprevalence of pertussis in the Netherlands: evidence for increased circulation of Bordetella pertussis. PLoS One 2010;5:e14183.
  • De Schutter I, Malfroot A, Dab I, Hoebrekx N, Muyldermans G, Pierard D, et al. Molecular typing of Bordetella pertussis isolates recovered from Belgian children and their household members. Clin Infect Dis 2003; 36:1391–6.
  • Klement E, Uliel L, Engel I, Hasin T, Yavzori M, Orr N, et al. An outbreak of pertussis among young Israeli soldiers. Epidemiol Infect 2003;131:1049–54.
  • Chinese Health Statistical Digest 47–48. China Ministry of Health; 2010.
  • Heininger U, Stehr K, Cherry JD. Serious pertussis overlooked in infants. Eur J Pediatr 1992;151:342–3.
  • Bass JW. Is there a carrier state in pertussis?Lancet 1987; 1:96.
  • Krantz I, Alestig K, Trollfors B, Zackrisson G. The carrier state in pertussis. Scand J Infect Dis 1986;18:121–3.
  • Linnemann CC Jr, Bass JW, Smith MH. The carrier state in pertussis. Am J Epidemiol 1968;88:422–7.
  • Srugo I, Benilevi D, Madeb R, Shapiro S, Shohat T, Somekh E, et al. Pertussis infection in fully vaccinated children in day-care centers, Israel. Emerg Infect Dis 2000;6:526–9.
  • He Q, Mertsola J, Soini H, Viljanen MK. Sensitive and specific polymerase chain reaction assays for detection of Bordetella pertussis in nasopharyngeal specimens. J Pediatr 1994;124:421–6.
  • Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol 2010;48:4459–63.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.